✦ LIBER ✦

A randomized, double-blind, placebo-controlled study using the standardized Psoriasis Area and Severity Index (PASI) to evaluate the efficacy and safety of oral-PUVA in patients with chronic plaque psoriasis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase IV randomized, double-blind, pla

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Safety and efficacy (PASI 90 and global

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A randomized, double-blind, placebo-cont

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

A randomized, double-blind, placebo-cont

✍ Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Randomized, double-blind, placebo-contro

✍ S. Priya Sivanesan; Shilpa Gattu; Judith Hong; Arianne Chavez-Frazier; Grace D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Efficacy and safety results from a phase

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB